Correlation Between Tandem Diabetes and Esperion Therapeutics

Can any of the company-specific risk be diversified away by investing in both Tandem Diabetes and Esperion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tandem Diabetes and Esperion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tandem Diabetes Care and Esperion Therapeutics, you can compare the effects of market volatilities on Tandem Diabetes and Esperion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tandem Diabetes with a short position of Esperion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tandem Diabetes and Esperion Therapeutics.

Diversification Opportunities for Tandem Diabetes and Esperion Therapeutics

-0.74

Correlation Coefficient

Tandem Diabetes  Esperion Therapeutics

Pay attention - limited upside

The 3 months correlation between Tandem and Esperion is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Tandem Diabetes Care and Esperion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Esperion Therapeutics and Tandem Diabetes is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tandem Diabetes Care are associated (or correlated) with Esperion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Esperion Therapeutics has no effect on the direction of Tandem Diabetes i.e., Tandem Diabetes and Esperion Therapeutics go up and down completely randomly.

Pair Corralation between Tandem Diabetes and Esperion Therapeutics

Given the investment horizon of 90 days Tandem Diabetes Care is expected to under-perform the Esperion Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Tandem Diabetes Care is 1.51 times less risky than Esperion Therapeutics. The stock trades about -0.11 of its potential returns per unit of risk. The Esperion Therapeutics is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  172.00  in Esperion Therapeutics on September 5, 2024 and sell it today you would earn a total of  153.00  from holding Esperion Therapeutics or generate 88.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Tandem Diabetes Care  vs.  Esperion Therapeutics

Tandem Diabetes Care

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tandem Diabetes Care has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Esperion Therapeutics

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Esperion Therapeutics are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Esperion Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Tandem Diabetes and Esperion Therapeutics

The main advantage of trading using opposite Tandem Diabetes and Esperion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tandem Diabetes position performs unexpectedly, Esperion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will offset losses from the drop in Esperion Therapeutics' long position.

The idea behind Tandem Diabetes Care and Esperion Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.